Aptar Pharma will unveil its Prohaler — the smart DPI for optimal patient compliance. It has been developed with to be intuitive and simple to use by asthma and COPD patients.Prohaler’s novel powder dispersion technology enables consistent lung deposition operating at relatively low patient inhalation flow rates. It requires three steps – open the device, inhale and close it; inhaling triggers the release of a full dose of médication and a dose counter reminds the patient how many doses are left in the device.
Prohaler also has a patient safety feature to avoid any risk of double-dosing and wasted doses.
Aptar Pharma, Hall 2, Stand F35